Mutual Advisors LLC bought a new position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

Follow all the transfer chaos with us LIVE! Kelty Hearts have confirmed the loan signing of Queen's Park youngster Liam ...

ImmunityBio shares were up 14% to $3.52 after the company entered into a collaboration and supply agreement with BeiGene. The two companies will conduct a confirmatory randomized Phase 3 clinical ...

ImmunityBio shares surged as much as 14% on Wednesday, reaching their highest level in nearly seven weeks while lifting ...

Wednesday's market has seen notable movements among various stocks, with some experiencing significant gains while others face declines. Mega-cap companies like T-Mobile (TMUS) and Nvidia Corp (NASDAQ ...